Resonance Specialties Inkomsten in het verleden
Verleden criteriumcontroles 3/6
Resonance Specialties's earnings have been declining at an average annual rate of -13%, while the Chemicals industry saw earnings growing at 15.6% annually. Revenues have been declining at an average rate of 1.3% per year. Resonance Specialties's return on equity is 6.7%, and it has net margins of 6%.
Belangrijke informatie
-13.0%
Groei van de winst
-13.1%
Groei van de winst per aandeel
| Chemicals Groei van de industrie | 17.7% |
| Inkomstengroei | -1.3% |
| Rendement op eigen vermogen | 6.7% |
| Nettomarge | 6.0% |
| Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe Resonance Specialties geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 24 | 671 | 40 | 50 | 0 |
| 30 Jun 24 | 591 | 27 | 50 | 0 |
| 31 Mar 24 | 553 | 30 | 48 | 0 |
| 31 Dec 23 | 573 | 35 | 47 | 0 |
| 30 Sep 23 | 515 | 34 | 47 | 0 |
| 30 Jun 23 | 564 | 44 | 44 | 0 |
| 31 Mar 23 | 588 | 50 | 43 | 0 |
| 31 Dec 22 | 599 | 64 | 46 | 0 |
| 30 Sep 22 | 666 | 84 | 45 | 0 |
| 30 Jun 22 | 701 | 104 | 45 | 0 |
| 31 Mar 22 | 758 | 124 | 43 | 0 |
| 31 Dec 21 | 765 | 120 | 40 | 0 |
| 30 Sep 21 | 780 | 128 | 41 | 0 |
| 30 Jun 21 | 818 | 134 | 41 | 0 |
| 31 Mar 21 | 709 | 105 | 40 | 0 |
| 31 Dec 20 | 645 | 95 | 36 | 0 |
| 30 Sep 20 | 627 | 83 | 36 | 0 |
| 30 Jun 20 | 534 | 54 | 37 | 0 |
| 31 Mar 20 | 573 | 55 | 42 | 0 |
| 31 Dec 19 | 616 | 65 | 41 | 0 |
| 30 Sep 19 | 565 | 45 | 37 | 0 |
| 30 Jun 19 | 515 | 38 | 31 | 0 |
| 31 Mar 19 | 426 | 32 | 33 | 0 |
| 31 Dec 18 | 377 | 11 | 41 | 0 |
| 30 Sep 18 | 349 | 12 | 40 | 0 |
| 30 Jun 18 | 374 | 6 | 36 | 0 |
| 31 Mar 18 | 367 | -8 | 38 | 0 |
| 31 Dec 17 | 359 | -12 | 31 | 0 |
| 30 Sep 17 | 340 | -6 | 35 | 0 |
| 30 Jun 17 | 335 | -3 | 37 | 0 |
| 31 Mar 17 | 347 | 10 | 35 | 0 |
| 31 Dec 16 | 354 | 20 | 34 | 0 |
| 30 Sep 16 | 365 | 10 | 32 | 0 |
| 30 Jun 16 | 382 | 14 | 28 | 0 |
| 31 Mar 16 | 391 | 12 | 29 | 0 |
| 31 Dec 15 | 378 | 7 | 58 | 6 |
| 30 Sep 15 | 382 | 8 | 57 | 6 |
| 30 Jun 15 | 374 | 8 | 26 | 0 |
| 31 Mar 15 | 382 | 13 | 28 | 0 |
| 31 Dec 14 | 401 | 10 | 56 | 8 |
| 30 Sep 14 | 401 | 8 | 56 | 8 |
| 30 Jun 14 | 430 | 12 | 56 | 8 |
| 31 Mar 14 | 453 | 10 | 57 | 8 |
| 31 Dec 13 | 436 | 6 | 54 | 3 |
Kwaliteitswinsten: 524218 has high quality earnings.
Groeiende winstmarge: 524218's current net profit margins (6%) are lower than last year (6.7%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 524218's earnings have declined by 13% per year over the past 5 years.
Versnelling van de groei: 524218's earnings growth over the past year (16.8%) exceeds its 5-year average (-13% per year).
Winst versus industrie: 524218 earnings growth over the past year (16.8%) exceeded the Chemicals industry 10.4%.
Rendement op eigen vermogen
Hoge ROE: 524218's Return on Equity (6.7%) is considered low.